Intermune (ITMN) March volatility at 220 on active volume into FDA meeting
Tweet Send to a Friend
Intermune (Nasdaq: ITMN) is recently up 85c to $16.46. The FDA's Pulmonary-Allergy Advisory Committee is expected to meet on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
